Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Thyroid Cancer Diagnostics Market Value Analysis: What Growth Is Expected Over The Forecast Period?
The market for thyroid cancer diagnostics has experienced robust expansion recently. Projections indicate a rise from its $3.15 billion valuation in 2025 to $3.34 billion by 2026, reflecting a compound annual growth rate of 6.0%. Key factors contributing to this historical growth include a greater prevalence of thyroid nodules, enhanced accessibility to ultrasound imaging, advancements in biopsy methodologies, the proliferation of cancer diagnostic facilities, and heightened clinical recognition of thyroid malignancies.
The market for thyroid cancer diagnostics is poised for significant expansion, projected to reach $4.25 billion by the year 2030, reflecting a compound annual growth rate of 6.2% during the forecast period. This anticipated growth is fueled by several key factors, including the escalating use of AI-powered imaging diagnostic tools, a growing need for customized oncology diagnostic solutions, the broader implementation of molecular testing panels, increased financial commitment to early cancer detection initiatives, and a heightened emphasis on precision diagnostic approaches. Furthermore, several significant trends are expected to shape this market, such as the expanding utilization of molecular diagnostic methodologies, the advancing integration of genetic testing, the proliferation of early detection programs, and a continuous drive towards improving both the accuracy and rapidity of diagnostic procedures.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12030&type=smp
Thyroid Cancer Diagnostics Market Growth Factors: Which Forces Are Supporting Market Expansion?
The escalating incidence of thyroid cancer is a significant catalyst for the expansion of the thyroid cancer diagnostic market. This condition affects the thyroid gland, a vital organ situated at the throat’s base responsible for hormone production that governs essential bodily functions like temperature regulation, heart rate, blood pressure, and weight management. Diagnostic tools for thyroid cancer play a crucial role in identifying the disease through early detection, which subsequently enhances treatment efficacy. Consequently, a rise in the occurrence of thyroid cancer directly fuels the demand within its diagnostic market. To illustrate, a September 2023 report from the American Cancer Society, a philanthropic organization based in the United States, estimated around 43,720 new thyroid cancer diagnoses for the year 2023, comprising 12,540 cases in males and 31,180 in females. The same year’s projection indicated approximately 2,120 fatalities attributed to thyroid cancer, with 970 deaths among men and 1,150 among women, underscoring how the growing prevalence of thyroid cancer is stimulating the market for its diagnostics.
Thyroid Cancer Diagnostics Market Segment Breakdown: Which Categories Generate The Most Revenue?
The thyroid cancer diagnostics market covered in this report is segmented –
1) By Technique Type: Imaging Test, Blood Test, Biopsy, Other Test Types
2) By Disease Type: Papillary Carcinoma, Follicular Carcinoma, Other Diseases
3) By End-User: Hospital Laboratories, Cancer Diagnostic Centers, Research Institutes, Other End-Users
Subsegments:
1) By Imaging Test: Ultrasound Imaging, Computed Tomography (CT) Scans, Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET) Scans, Radioactive Iodine Scans
2) By Blood Test: Thyroid Function Tests, Tumor Marker Tests, Genetic Testing For Thyroid Cancer
3) By Biopsy: Fine Needle Aspiration (FNA) Biopsy, Core Needle Biopsy, Surgical Biopsy
4) By Other Test Type: Molecular Diagnostics, Immunohistochemistry Tests, Histopathological Analysis
Thyroid Cancer Diagnostics Market Industry Trends: What Changes Are Reshaping Demand?
Leading entities within the thyroid cancer diagnostic sector are actively creating advanced methods, notably RNA sequencing tests, aimed at improving the precision of identifying cancer fusions in a variety of solid tumors, including thyroid malignancies. RNA sequencing, often abbreviated as RNA-Seq, represents a sophisticated, high-volume analytical approach that allows for the measurement of both the amount and specific sequence of RNA present in biological specimens, thereby illuminating gene expression patterns and the complete RNA profile. As a salient example, in May of 2024, Foundation Medicine, Inc., a biotechnology firm headquartered in the United States, unveiled the U.S. release of FoundationOne RNA. This particular offering is a tissue-derived RNA sequencing examination engineered to pinpoint gene fusions linked to cancer across a comprehensive panel of 318 genes. The test furnishes fusion detection reports applicable to all types of solid tumors and holds significant potential for detecting fusions in oncological conditions such as non-small cell lung cancer (NSCLC), sarcomas, pancreatic cancers, thyroid cancers, cholangiocarcinomas, and bladder cancers.
Thyroid Cancer Diagnostics Market Key Players And Strategic Industry Positioning
Major companies operating in the thyroid cancer diagnostics market are General Electric, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Toshiba Corporation, Siemens Healthcare GmbH, FUJIFILM Holdings Corporation, Koninklijke Philips N.V., Agilent Technologies Inc., Hologic Inc., Illumina Inc., BioMérieux SA, Bio-Rad Laboratories Inc., Quest Diagnostics Inc., Qiagen N.V., Cepheid, Veracyte Inc., DiaSorin S.p.A., Myriad Genetics Inc., Interpace Biosciences, Guardant Health, BillionToOne, Canon Inc., Beckman Coulter Inc.
Access The Complete Thyroid Cancer Diagnostics Market Report:
https://www.thebusinessresearchcompany.com/report/thyroid-cancer-diagnostics-global-market-report
Thyroid Cancer Diagnostics Market Largest Region By Revenue And Market Share
North America was the largest region in the thyroid cancer diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the thyroid cancer diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
